Articles

Going viral

Researchers discover that viruses for both microorganisms and humans commandeer the ESCRT proteins in order to spread
Written byKelsey Kaustinen
| 2 min read

BLOOMINGTON, Ind.—Biologists have known for years thatviruses spread by infecting new cells, but a recent study by researchers fromIndiana University and Montana State University has indicated that theinfection of the cells might be more specific. The researchers' work discovered thatviruses such as HIV and Ebola, and viruses that infect organisms known as archaea(which grow in volcanic hot springs), both commandeer a certain set of proteinsin order to escape from infected cells. The group that these viruses hijack inboth eukaryotes (plants and animals) and archaea are called the endosomal sorting complexes required for transport (ESCRT). Scientists have dated archaeaback to 3.7 billion years, with the oldest fossils of eukaryotes dating back to1.7 billion years.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of a single cell surrounded by small molecular particles in a red biological environment.
Measuring mRNA and protein together at single cell resolution can uncover tumor-specific signaling activity and immune features.
Illustration of an antibody intertwined with a DNA double helix.
Discover how CRISPR and single-cell RNA sequencing can connect disease-associated variants to regulatory elements, genes, and pathways.
Digital illustration of the human digestive system highlighting the liver, stomach, and intestines.
Explore how human gut-liver models can improve the translation of preclinical findings into clinical pharmacokinetic predictions.